US Food and Drug Administration(FDA) has withdrawn emergency authorization of hydroxychloroquine(HCQ) and chloroquine (CQ) to treat coronavirus patients. Also Read: Latin America and Caribbean pass 80,000 COVID-19 deaths as global cases top 8 million "It is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19," Denise Hinton, head scientist, FDA, said, adding,"nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risk.

US withdraws emergency authorization of hydroxychloroquine, chloroquine for coronavirus patients

The debate is raging again. This time more than hundred scientists have questioned the authenticity of the much-hyped Lancet study. After the Lancet report, the World Health Organisation(WHO) had decided to suspend HCQ trials.

Is hydroxychloroquine a 'miracle' drug or a death pill?

The Narendra Modi government has decided to partially lift the ban on the export of two key drugs, hydroxychloroquine and paracetamol,

India partially lifts ban on export of HCQ

hcq-ban

Hcq Ban, News on Hcq Ban, stories on Hcq Ban, articles on Hcq Ban, Hcq Ban stories at Wion, Hcq Ban news, Hcq Ban latest news

hcq ban

US withdraws emergency authorization of hydroxychloroquine, chloroquine for coronavirus patients

Is hydroxychloroquine a 'miracle' drug or a death pill?

India partially lifts ban on export of HCQ